159
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

ORCID Icon, , , , , , , ORCID Icon, , , & ORCID Icon show all
Pages 1479-1483 | Received 08 Sep 2021, Accepted 19 Dec 2021, Published online: 12 Jan 2022
 

Disclosure statement

The authors report no conflict of interest.

Additional information

Funding

This work was made possible through Aarhus University, the Karen Elise Jensen Foundation, the Eva and Henry Fraenkel Foundation, the Einar Willumsen’s Memorial Foundation, and the Danish Lymphoma Group.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.